Skip to main content
. 2012 Apr;19(2):e75–e83. doi: 10.3747/co.19.879

TABLE II.

Hematologic adverse events

Event Gradea[n (%) patients]
1 2 3
Anemia 16 (34) 12 (26) 3 (6)
Febrile neutropenia 0 (—) 0 (—) 1 (2)
Leukopenia 5 (11) 5 (11) 4 (9)
Neutropenia 9 (19) 3 (6) 2 (4)
Thrombocytopenia 13 (28) 1 (2) 1 (2)
a

Evaluated according to the Common Terminology Criteria for Adverse Events, version 3.0.